THY1 and cancer: There were limited data on TAM-related miR-125a and miR-22 in cancers, but the transfer of miR-125a or miR-125b to TAMs can suppress cancer cell proliferation and stem cell properties by targeting CD90, a stem cell marker for hepatocellular carcinoma [36].